University of Michigan Rogel Cancer Center: Drug Targets Identified for Pancreatic Cancer
June 03, 2025
June 03, 2025
ANN ARBOR, Michigan, June 3 (TNSjou) -- The University of Michigan Rogel Cancer Center issued the following news release:
* * *
Drug targets identified for pancreatic cancer
Simultaneous targeting of PIKfyve and KRAS-MAPK eliminates tumors in preclinical human and mouse models
Pancreatic cancer is a leading cause of cancer-related death, with a five-year survival rate of 13%. The high mortality is largely due to a lack of effective therapy opti . . .
* * *
Drug targets identified for pancreatic cancer
Simultaneous targeting of PIKfyve and KRAS-MAPK eliminates tumors in preclinical human and mouse models
Pancreatic cancer is a leading cause of cancer-related death, with a five-year survival rate of 13%. The high mortality is largely due to a lack of effective therapy opti . . .